ArticleJournal of family medicine and primary care2025
A three-year retrospective study of infectious hepatitis at a teaching hospital in Northern India.
Article in Journal of family medicine and primary care, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Infectious hepatitis is primarily attributed to hepatitis A virus (HAV) and hepatitis E virus (HEV) infections, which exhibit distinct geographical distribution patterns and varying prevalence rates worldwide, influenced by factors such as sanitation, hygiene, and socioeconomic conditions. Due to the paucity of prevalence data, the exact burden of the disease in Northern India is not established. Materials and Methods: This retrospective observational study, conducted over 3 years (January 2022 to December 2024), analyzed serum samples from patients presenting with clinical features of acute viral hepatitis (AVH) at a tertiary care teaching hospital in Northern India. ELISA-based detection of IgM antibodies against HAV and HEV was performed on 1203 and 1102 serum samples, respectively. Results: The seroprevalence of HAV and HEV in our study was 28.76% and 3.45%, respectively. A notable finding was the low co-infection rate of HAV and HEV ( Conclusion: Regular diagnosis of AVH etiology, coupled with ongoing case monitoring, is crucial for effective patient management and to inform evidence-driven policy formulation for disease control initiatives.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.